At a glance
CDC works with partners in Angola to strengthen the country's public health and clinical systems; deliver quality HIV testing and treatment services; and respond to emerging public health threats.
Background
CDC established a partnership with the Angola Ministry of Health (MOH) in 2002 to strengthen the national public health system. In 2004, CDC began efforts to build capacity within the MOH to respond to the HIV/AIDS epidemic. CDC also works with the Instituto Nacional de Luta Contra o SIDA's (INLS).
Our collaboration with Angola is focused on strengthening public health and clinical systems and delivering quality HIV testing and treatment services. CDC also supports partners in Angola to respond to emerging public health threats.
CDC's strategic focus includes working with implementing partners to:
- Build public health capacity and infrastructure
- Strengthen health information systems
Download CDC Angola's Fact Sheet
HIV and TB key data
HIV/AIDS
Estimated HIV Prevalence (Ages 15-49)
Estimated AIDS Deaths (Age≥15)
Estimated Orphans Due to AIDS
Reported Number Receiving Antiretroviral Therapy (Age≥15)
Tuberculosis (TB)
Estimated TB Incidence
TB Patients with Known HIV-Status who are HIV-Positive
TB Treatment Success Rate
Key activities and accomplishments
Building public health capacity
CDC implements HIV programs in 22 health facilities across the four provinces of Benguela, Cunene, Huambo, and Lunda Sul. CDC collaborates with the MOH to support a combined facility-community approach for index testing. This approach helps to maximize the impact of HIV testing at PEPFAR-supported health facilities.
CDC helps implement the "Test and Treat" program, which starts treatment for patients the same day they are diagnosed with HIV. Medication adherence and sustained use of antiretroviral treatment (ART) is key to ending HIV. This is why CDC provides retention-focused technical assistance to health facilities and healthcare providers in Angola. CDC also supports work in communities to integrate HIV and tuberculosis (TB) care and treatment.
Strengthening HIV/AIDS policies
CDC's technical assistance to the MOH and INLS facilitated key HIV policy changes in Angola. These changes include updated ART regimens to include Tenofovir Lamivudine Dolutegravir for adults and children. Another policy change led to the dispensing of up to three months of ART to patients to decrease interruptions in treatment. Finally, CDC collaborated with partners to revise national HIV laboratory procedures.
Strengthening laboratory systems and networks
CDC collaborated with partners to develop laboratory quality assurance/management systems and build laboratory capacity. These efforts helped to enhance the quality of HIV diagnostic and management services. CDC also supported the development of a national point of care early infant diagnosis testing package. This package included a transport network for laboratory samples from health facilities. It also included implementation of an electronic laboratory information system to track HIV-exposed children.
Strengthening health information systems
CDC supported Angola in conducting a thorough assessment of the country's HIV/TB data quality system. This effort improved monitoring and evaluation systems and piloted a facility-based electronic HIV patient tracking system.
CDC also collaborated with the MOH to develop a national register of patients with HIV at each PEPFAR-supported point of service. This register helped to deduplicate data and improve linkage to treatment and retention of patients.
Resources
Support for CDC's global HIV and TB efforts.
Our success is built on the backbone of science and strong partnerships.